
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 (COVID-19) and cystic fibrosis
Bruce A. Stanton, Thomas H. Hampton, Alix Ashare
AJP Lung Cellular and Molecular Physiology (2020) Vol. 319, Iss. 3, pp. L408-L415
Open Access | Times Cited: 49
Bruce A. Stanton, Thomas H. Hampton, Alix Ashare
AJP Lung Cellular and Molecular Physiology (2020) Vol. 319, Iss. 3, pp. L408-L415
Open Access | Times Cited: 49
Showing 26-50 of 49 citing articles:
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS‐CoV ‐2 infection and COVID ‐19 disease severity
Philip R. Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 4
Philip R. Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 4
Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice
Giovanni Sarnelli, Alessandro Re, Irene Palenca, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116441-116441
Open Access | Times Cited: 1
Giovanni Sarnelli, Alessandro Re, Irene Palenca, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116441-116441
Open Access | Times Cited: 1
Beyond Borders of the Cell: How Extracellular Vesicles Shape COVID-19 for People with Cystic Fibrosis
Ewelina D. Hejenkowska, Hayrettin Yavuz, Agnieszka Swiatecka‐Urban
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3713-3713
Open Access | Times Cited: 1
Ewelina D. Hejenkowska, Hayrettin Yavuz, Agnieszka Swiatecka‐Urban
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3713-3713
Open Access | Times Cited: 1
COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes
Kelly Mason, S. N. Hasan, Amy Darukhanavala, et al.
Journal of Clinical & Translational Endocrinology (2021) Vol. 26, pp. 100268-100268
Open Access | Times Cited: 9
Kelly Mason, S. N. Hasan, Amy Darukhanavala, et al.
Journal of Clinical & Translational Endocrinology (2021) Vol. 26, pp. 100268-100268
Open Access | Times Cited: 9
A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021
Helen L. Barr, Tiphaine Bihouée, Annelies M. Zwitserloot
Journal of Cystic Fibrosis (2022) Vol. 21, Iss. 2, pp. 191-196
Open Access | Times Cited: 6
Helen L. Barr, Tiphaine Bihouée, Annelies M. Zwitserloot
Journal of Cystic Fibrosis (2022) Vol. 21, Iss. 2, pp. 191-196
Open Access | Times Cited: 6
Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks
Virginia Lotti, Anna Lagni, Erica Diani, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
Virginia Lotti, Anna Lagni, Erica Diani, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes
Paola Medino, Gianfranco Alicandro, Chiara Rosazza, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2771-2771
Open Access | Times Cited: 5
Paola Medino, Gianfranco Alicandro, Chiara Rosazza, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2771-2771
Open Access | Times Cited: 5
Current evidence on the effect of highly effective CFTR modulation on interleukin-8 in cystic fibrosis
Michael Williamson, Michelle Casey, Claudie Gabillard-Lefort, et al.
Expert Review of Respiratory Medicine (2021) Vol. 16, Iss. 1, pp. 43-56
Closed Access | Times Cited: 6
Michael Williamson, Michelle Casey, Claudie Gabillard-Lefort, et al.
Expert Review of Respiratory Medicine (2021) Vol. 16, Iss. 1, pp. 43-56
Closed Access | Times Cited: 6
The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists
Amy J. Lee, Julie L. Huffmyer, Eryn L. Thiele, et al.
Anesthesia & Analgesia (2022)
Closed Access | Times Cited: 4
Amy J. Lee, Julie L. Huffmyer, Eryn L. Thiele, et al.
Anesthesia & Analgesia (2022)
Closed Access | Times Cited: 4
Cystic fibrosis in children: A pediatric anesthesiologist’s perspective
Danielle M. Williamson, Anshuman Sharma
Pediatric Anesthesia (2021) Vol. 32, Iss. 2, pp. 167-173
Closed Access | Times Cited: 4
Danielle M. Williamson, Anshuman Sharma
Pediatric Anesthesia (2021) Vol. 32, Iss. 2, pp. 167-173
Closed Access | Times Cited: 4
Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis
Kathleen Mahan, S. Kiel, Rebecca Freese, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27567-e27567
Open Access
Kathleen Mahan, S. Kiel, Rebecca Freese, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27567-e27567
Open Access
E.PathDash, pathway activation analysis of public cystic fibrosis pathogen gene expression data
Lily Taub, Thomas H. Hampton, Sharanya Sarkar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Lily Taub, Thomas H. Hampton, Sharanya Sarkar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Occurrence of COVID-19 in cystic fibrosis patients: a review
F Abolhasani, Masood Moein, Niloofar Rezaie, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
F Abolhasani, Masood Moein, Niloofar Rezaie, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
E.PathDash, pathway activation analysis of publicly available pathogen gene expression data
Lily Taub, Thomas H. Hampton, Sharanya Sarkar, et al.
mSystems (2024) Vol. 9, Iss. 11
Open Access
Lily Taub, Thomas H. Hampton, Sharanya Sarkar, et al.
mSystems (2024) Vol. 9, Iss. 11
Open Access
Respiratory Care in Children with COVID-19
Shalu Gupta, Suresh Kumar Angurana, Virendra Kumar
Journal of Pediatric Intensive Care (2021) Vol. 12, Iss. 02, pp. 087-093
Open Access | Times Cited: 3
Shalu Gupta, Suresh Kumar Angurana, Virendra Kumar
Journal of Pediatric Intensive Care (2021) Vol. 12, Iss. 02, pp. 087-093
Open Access | Times Cited: 3
Expression of ACE2—a Key SARS-CoV-2 Entry Factor—Is Not Increased in the Nasal Mucosa of People with Cystic Fibrosis
Marc A. Sala, Nikolay S. Markov, Yuliya Politanska, et al.
American Journal of Respiratory Cell and Molecular Biology (2022) Vol. 67, Iss. 1, pp. 132-137
Open Access | Times Cited: 2
Marc A. Sala, Nikolay S. Markov, Yuliya Politanska, et al.
American Journal of Respiratory Cell and Molecular Biology (2022) Vol. 67, Iss. 1, pp. 132-137
Open Access | Times Cited: 2
Impactul COVID-19 asupra bolilor cronice pulmonare la copil: Astmul și fibroza chistică
Laura-Larisa Dracea
Romanian Journal of Pediatrics (2020) Vol. 69, Iss. 4, pp. 291-294
Open Access | Times Cited: 1
Laura-Larisa Dracea
Romanian Journal of Pediatrics (2020) Vol. 69, Iss. 4, pp. 291-294
Open Access | Times Cited: 1
Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis: Correspondence
Mohanchandra Mandal, Susanta Sarkar, António M. Esquinas
The Indian Journal of Pediatrics (2022) Vol. 89, Iss. 8, pp. 841-841
Open Access | Times Cited: 1
Mohanchandra Mandal, Susanta Sarkar, António M. Esquinas
The Indian Journal of Pediatrics (2022) Vol. 89, Iss. 8, pp. 841-841
Open Access | Times Cited: 1
Management of chronic pulmonary disease in the time of coronavirus disease 2019
J. Palla, Theresa A. Laguna
Current Opinion in Pediatrics (2021) Vol. 33, Iss. 3, pp. 294-301
Open Access | Times Cited: 1
J. Palla, Theresa A. Laguna
Current Opinion in Pediatrics (2021) Vol. 33, Iss. 3, pp. 294-301
Open Access | Times Cited: 1
Reply to Eisenhut
Reem Abdel Hameid, Estelle Cormet‐Boyaka, Wolfgang M. Kuebler, et al.
AJP Lung Cellular and Molecular Physiology (2021) Vol. 321, Iss. 1, pp. L287-L289
Open Access | Times Cited: 1
Reem Abdel Hameid, Estelle Cormet‐Boyaka, Wolfgang M. Kuebler, et al.
AJP Lung Cellular and Molecular Physiology (2021) Vol. 321, Iss. 1, pp. L287-L289
Open Access | Times Cited: 1
An Evaluation of the Risk Factors and Respiratory Function Test Change of Children with Cystic Fibrosis Who Contracted COVID-19 Infection
Mehmet Mustafa Özaslan, Handan Duman Şenol, Meral Barlık, et al.
Journal of Pediatric Infectious Diseases (2023) Vol. 18, Iss. 05, pp. 232-239
Closed Access
Mehmet Mustafa Özaslan, Handan Duman Şenol, Meral Barlık, et al.
Journal of Pediatric Infectious Diseases (2023) Vol. 18, Iss. 05, pp. 232-239
Closed Access
The clinical features and impact of SARS-CoV-2/COVID-19 infection in children with Cystic Fibrosis (CF): A Qatari experience
Sara G. Hamad, H. Kammouh, Mohammed Alamri, et al.
Qatar medical journal (2023) Vol. 2023, Iss. 3
Open Access
Sara G. Hamad, H. Kammouh, Mohammed Alamri, et al.
Qatar medical journal (2023) Vol. 2023, Iss. 3
Open Access
Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog
Gerald H. Lushington, Annika Linde, Tonatiuh Melgarejo
BioTech (2023) Vol. 12, Iss. 4, pp. 61-61
Open Access
Gerald H. Lushington, Annika Linde, Tonatiuh Melgarejo
BioTech (2023) Vol. 12, Iss. 4, pp. 61-61
Open Access
Impact of COVID-19 on chronic lung disease in children: Asthma and cystic fibrosis
Laura-Larisa Dracea
Romanian Journal of Pediatrics (2020) Vol. 69, Iss. 4, pp. 287-290
Open Access
Laura-Larisa Dracea
Romanian Journal of Pediatrics (2020) Vol. 69, Iss. 4, pp. 287-290
Open Access
SARS-CoV-2 and Cystic Fibrosis: Expectations Versus Reality, a Literature Review
Maria Anna Bantounou, Josip Plascevic
EMJ Respiratory (2021)
Open Access
Maria Anna Bantounou, Josip Plascevic
EMJ Respiratory (2021)
Open Access